CONSOLI, Agostino
 Distribuzione geografica
Continente #
NA - Nord America 7.133
EU - Europa 6.506
AS - Asia 4.174
SA - Sud America 256
AF - Africa 39
Continente sconosciuto - Info sul continente non disponibili 17
OC - Oceania 4
Totale 18.129
Nazione #
US - Stati Uniti d'America 7.093
CN - Cina 1.436
SG - Singapore 1.435
UA - Ucraina 1.182
IE - Irlanda 1.117
IT - Italia 971
TR - Turchia 917
SE - Svezia 748
GB - Regno Unito 703
FR - Francia 689
DE - Germania 451
FI - Finlandia 257
IN - India 227
BR - Brasile 224
RU - Federazione Russa 217
HK - Hong Kong 54
NL - Olanda 33
CA - Canada 30
CZ - Repubblica Ceca 28
BE - Belgio 24
VN - Vietnam 23
PL - Polonia 18
AT - Austria 17
EG - Egitto 17
EU - Europa 16
KR - Corea 14
AR - Argentina 12
RO - Romania 11
ES - Italia 10
IL - Israele 10
IQ - Iraq 8
BD - Bangladesh 6
BG - Bulgaria 6
JP - Giappone 6
PK - Pakistan 6
ZA - Sudafrica 6
CO - Colombia 5
IR - Iran 5
MA - Marocco 5
MX - Messico 5
TW - Taiwan 5
EC - Ecuador 4
GR - Grecia 4
PE - Perù 4
PT - Portogallo 4
AE - Emirati Arabi Uniti 3
AU - Australia 3
CH - Svizzera 3
KE - Kenya 3
MY - Malesia 3
PH - Filippine 3
SA - Arabia Saudita 3
VE - Venezuela 3
AZ - Azerbaigian 2
CL - Cile 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
HU - Ungheria 2
ID - Indonesia 2
LK - Sri Lanka 2
SC - Seychelles 2
UZ - Uzbekistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
BJ - Benin 1
BO - Bolivia 1
CR - Costa Rica 1
DZ - Algeria 1
GE - Georgia 1
IM - Isola di Man 1
JM - Giamaica 1
JO - Giordania 1
LI - Liechtenstein 1
LT - Lituania 1
LU - Lussemburgo 1
LV - Lettonia 1
NG - Nigeria 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PA - Panama 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
UG - Uganda 1
UY - Uruguay 1
Totale 18.129
Città #
Jacksonville 1.356
Chandler 1.297
Dublin 1.112
Singapore 855
Southend 556
Princeton 538
Izmir 498
Nanjing 383
Dearborn 376
Ashburn 273
Wilmington 252
Cambridge 221
Beijing 212
The Dalles 152
Santa Clara 151
Nanchang 148
Ann Arbor 145
Altamura 140
Boardman 114
Pescara 104
Los Angeles 100
Shenyang 99
Chieti 96
Woodbridge 91
Hebei 68
Kunming 64
Grevenbroich 61
Tianjin 60
Jiaxing 56
Hong Kong 52
Norwalk 52
Rome 52
Washington 51
Moscow 38
Changsha 35
Helsinki 35
Milan 34
New York 33
Ningbo 32
Cedar Knolls 31
Hangzhou 31
Falls Church 27
Orange 27
Munich 26
Houston 25
Jinan 25
Dong Ket 23
Guangzhou 23
Nuremberg 23
Brno 22
Brussels 20
San Mateo 19
Hefei 17
Changchun 16
Frankfurt am Main 16
Leawood 16
Toronto 16
Augusta 14
São Paulo 14
Zhengzhou 14
Lanzhou 13
Auburn Hills 12
Florence 12
London 12
Rio de Janeiro 12
Alexandria 11
Kocaeli 11
Naples 11
Palermo 11
Seattle 11
Shanghai 11
Taizhou 11
Vienna 11
Lappeenranta 10
Guardiagrele 9
Kraków 9
Viterbo 9
Wŏnju 9
Ottawa 8
Simi Valley 8
Venice 8
Bari 7
Chengdu 7
San Vito Chietino 7
Tappahannock 7
Hackney 6
Istanbul 6
Madrid 6
Romola 6
Amsterdam 5
Belo Horizonte 5
Bialystok 5
Castellammare di Stabia 5
Catania 5
Chicago 5
Düsseldorf 5
Fuzhou 5
Lissone 5
Mountain View 5
Mumbai 5
Totale 10.763
Nome #
Policaptil Gel Retard® reduces body weight and improves insulin sensitivity in obese subjects 151
Vitamin E supplementation normalizes LDL susceptibility to oxidation in well controlled uncomplicated type II diabetes mellitus 141
Adherence of Uremic Erythrocytes to Vascular Endothelium decreases Endothelial Nitric Oxide Synthase Expression 132
A comparative safety review between GLP-1 receptor agonists and SGLT2 inhibitors for diabetes treatment 131
Principi di Endocrinologia 128
Postprandial hyperglycemia is a determinant of platelet activation in early type 2 diabetes mellitus 128
Obesity modifies the effects of the Asp905Tyr variant of PPP1R3A on risk of type 2 diabetes and insulin sensitivity 125
Il trattamento con Metformina riduce i livelli di alcuni indicatori di stress ossidativi in diabetici di tipo 2 122
Centella Asiatica inhibits TNFα-induced adhesion molecule expression in endothelial cells of umbilical cords from gestational diabetic women. 122
Effect of an L-carnitine-containing peritoneal dialysate on insulin sensitivity in patients treated with CAPD: a 4-month, prospective, multicenter randomized trial. 122
Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial 121
Relationship between patient-practice oriented knowledge and metabolic control in intensively treated Type 1 diabetic patient: Result of the validation of the knowledge and Practices Diabetes Questionnaire 117
Mechanisms of uremic erytrocyte-induced adhesion of human monocytes to cultured endothelial cells 114
Preliminari esperienze terapeutiche del diabete in gravidanza 111
Phenotype modulation in cultures of vascular smooth muscle cells from diabetic rats: association with increased nitric oxide synthase expression and superoxide anion generation. 110
Thromboxane-dependent CD40 ligand release in type 2 diabetes mellitus 107
Insulin enhances vascular adhesion molecule (VCAM-1) expression in human cultured endothelial cells through a pro-atherogenic p38MAP-kinase mediated pathway. 106
In vivo thromboxane-dependent platelet activation is persistently enhanced in subjects with impaired glucose tolerance 106
Transmural distribution of antioxidant defences and lipid peroxidation in the rabbit left ventricular myocardium 104
ENPP1 Q121 variant, increased pulse pressure and reduced insulin signaling, and nitric oxide synthase activity in endothelial cells. Arterioscler Thromb Vasc Biol. 2009 Oct;29(10):1678-83. 104
TRIB3 R84 variant is associated with impaired insulin-mediated nitric oxide production in human endothelial cells. 102
Endocrinologia Clinica 102
Association of kidney disease measures with risk of renal function worsening in patients with type 1 diabetes 11 Medical and Health Sciences 1103 Clinical Sciences 101
Do thiazolidinediones still have a role in treatment of type 2 diabetes mellitus? 100
Features of endothelial dysfunction in umbilical cord vessels of women with gestational diabetes 100
Effects of Liraglutide on Weight Loss, Fat Distribution, and β-Cell Function in Obese Subjects With Prediabetes or Early Type 2 Diabetes 100
Heightened free radical activity in angina pectoris 99
[Type 2 diabetes treatment and cardiovascular risk: what can we learn from trials?] 99
DHEA mimics acute actions of insulin to stimulate production of both NO and ET-1 via distinct PI 3-kinase- and MAP-kinase-dependent pathways in vascular endothelium. 99
MicroRNA profiling reveals new potential modulators of insulin-resistance and cardiovascular risk in type 2 diabetes 97
Circulating dickkopf-1 in diabetes mellitus: association with platelet activation and effects of improved metabolic control and low-dose aspirin. 96
Chronic in vivo hyperglycaemia increases nitroxidant stress and hinders nitric oxide availability in human vessels and human endothelial cells 96
Arterial wall and liver of diabetic rats exhibit increased synthesis of plasminogen activator inhibitor-1 (PAI-1). 94
Plasma exosome microRNA profiling unravels a new potential modulator of adiponectin pathway in diabetes: effect of glycemic control 94
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) regulates endothelial nitric oxide synthase (eNOS) activity and its localization within the human vein endothelial cells (HUVEC) in culture. 93
Acute hyperglycemia and acute hyperinsulinemia both decrease plasma fibrinolytic activity and increase plasminogen activator type-1 (PAI-1) in the rat. 92
Valutazione del fabbisogno insulinico post-prandiale in pazienti diabetici trattati con microinfusore insulinico 92
Decreased in vivo oxidative stress and decreased platelet activation following metformin treatment in newly diagnosed type 2 diabetes subjects 91
Combined effect of glucose and insulin in stimulating plasminogen activator inhibitor-1 secretion and gene expression in human vascular smooth muscle cells in culture 91
Variations in carbohydrate, lipid and protein oxidation evaluated by indirect calorimetry in obese subjects on a "single-meal" low-calorie diet. 91
Liraglutide improves memory in obese patients with prediabetes or early type 2 diabetes: a randomized, controlled study 91
Cigarette smoke, ferritin, and lipid peroxidation 91
Plasminogen Activator Inhibitor-1 synthesis is increased in arterial wall of diabetic subjects 90
Phenylmethimazole reverses plasminogen activator inhibitor-1 (PAI-1) overexpression in diabetic rats 90
Liraglutide and cardiovascular outcomes in type 2 diabetes 90
Thromboxane-dependent platelet activation in obese subjects with prediabetes or early type 2 diabetes: Effects of liraglutide-or lifestyle changes-induced weight loss 90
Evaluation of metalloproteinase 2 and 9 levels and their inhibitors in diabetic and healthy subjects. 89
Inositol and antioxidant supplementation: Safety and efficacy in pregnancy 89
Treatment of brittle diabetes by continuous subcutaneous in-insulin infusion. Comparison with conventional treatment 88
Iperespressione dell'inibitore dell'attivatore del plasminogeno di tipo 1 (PAI-1) nel fegato e nella aorta di ratti diabetici 87
The TRIB3 R84 variant is associated with increased carotid intima-media thickness in vivo and with enhanced MAPK signalling in human endothelial cells. 87
Selective insulin resistance affecting nitric oxide release but nor plasminogen activator inhibitor-1 synthesis in fibroblast from insulin-resistant individuals. 86
Semaglutide and cardiovascular outcomes in patients with type 2 diabetes 86
Assorbimento dell’insulina umana semisintetica dopo iniezione sottocutanea a spruzzo transcutaneo mediante iniettore 85
I glitazoni 85
Treatment of unstable diabetes by continuous subcutaneous infusion of insulin. 85
MicroRNA profiling reveals new potential modulators of insulin-resistance in type 2 Diabetes 85
La terapia insulinica: tradizione e novità 85
Platelets as a source of CD40 ligand in type 2 diabetes mellitus 85
Ruolo del fegato 84
Synergic effect of glucose and insulin in stimulating plasminogen activator inhibitor 1 (PAI-1) expression and secretion in human vascular smooth cells (vSMC) 84
I livelli di inibitore dell’attivatore del plasminogeno-1 (PAI-1) risultano aumentati nella parete arteriosa di pazienti diabetici 84
Blood sugar control in diabetic patients bearing microinfusors: the importance of the dawn phenomenon 84
Decreased expression of the plasminogen activator inhibitor-1 (PAI-1) gene in diabetic rats treated with phenylmethimazole 84
Distribuzione transmurale dei sistemi antiossidanti e della perossidazione lipidica nel ventricolo sinistro di coniglio 84
Rationale and design of the DARWIN-T2D (DApagliflozin Real World evIdeNce in Type 2 Diabetes): A multicenter retrospective nationwide Italian study and crowdsourcing opportunity 84
An increased osteoprotegerin serum release characterizes the early onset of diabetes mellitus and may contribute to endothelial cell dysfunction. 83
MicroRNA profiling reveals new potetial modulators of insulin resistance and cardiovascular risk in type 2 diabetes 83
Transcriptome analysis of human primary endothelial cells (HUVEC) from umbilical cords of Gestational Diabetic mothers reveals candidate sites for an epigenetic modulation of specific gene expression. 83
Liraglutide mitigates TNF-alfa induced pro-atherogenic changes and microvesicle release in HUVEC from diabetic women 83
Ottimizzazione della terapia con insulina basale nel DM2: add-on di GLP-1 RA in associazione libera e in combinazione pre-costituita 83
A functional variant of the dimethylarginine dimethylaminohydrolase-2 gene is associated with insulin sensitivity. 83
La dieta ipocalorica nella terapia del diabete di tipo 2 con obesità. Confronto con dieta ipo- e normoglicidica a differente contenuto calorico. 82
Both acute and chronic hyperglycemia decrease plasma fribrinolytic activity in the rat. 82
The prominent role of p38 mitogen-activated protein kinase in insulin-mediated enhancement of VCAM-1 expression in endothelial cells. 82
Effects of a "single-meal" low calorie diet on the circadian variation of serum cortisol, insulin and somatotropin and urinary excretion of catecholamines. 82
Deletion of Gly723 in the insulin receptor substrate-1 of a patient with noninsulin-dependent diabetes mellitus. 82
Iperespressione dell’inibitore dell’attivatore del plasminogeno di tipo 1 (PAI-1) nel fegato e nell’aorta di ratti diabetici 81
The dawn phenomenon in Type I (insulin-dependent) diabetic patient treated by continuous subcutaneous insulin infusion. 81
The C242T polymorphism of the p22phox component of NAD(P)H oxidase and vascular risk. Two case-control studies and a meta-analysis. 81
Difetti Beta cellulari nel diabete di tipo 2 81
In vivo formation of 8-epi-prostaglandin F2alpha in diabetes mellitus. Effects of tight metabolic control and vitamin E supplementation. (pubbl su Suppl Thromb Haemostas) 80
Increased Plasminogen Activator Inhibitor (PAI-1) Synthesis and Gene Expression in Adipocyte of Diabetic Rats 80
Valutazione dell’efficacia delle prestazioni nel servizio di diabetologia: impatto dell’emoglobina glicata 80
Soluble RAGE in type 2 diabetes: association with oxidative stress. 80
In vivo formation of 8-iso-prostaglandin f2alpha and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementation. 80
Administration of semisynthetic human insulin by a spray injector 80
Joint effect of insulin signaling genes on cardiovascular events and on whole body and endothelial insulin resistance. 80
G972R IRS-1 variant impairs insulin regulation of eNOS in cultured human endothelial cells 79
Short term vitamin E treatment normalizes LDL oxidative susceptibility in diabetic subjects 78
Exenatide promotes cognitive enhancement and positive brain metabolic changes in PS1-KI mice but has no effects in 3xTg-AD animals 78
Can the glucose load test predict insulin requirement in gestational diabetes with normal fasting blood glucose (Type B)?. 77
Postprandial hyperglycemia is an important determinant of platelet activation. evidence from biochemical measurements and pharmacological intervention with acarbose 77
A high-score Mediterranean dietary pattern is associated with a reduced risk of peripheral arterial disease in Italian patients with Type 2 diabetes 77
Il sintomo impotenza come esordio di una neuropatia diabetica nel paziente di sesso maschile 76
Potential side effects to GLP-1 agonists: Understanding their safety and tolerability 76
Glucose and insulin independently reduce the fibrinolytic potential of human vascular smooth muscle cells in culture. 76
L’impatto socio-economico delle ipoglicemie 75
Cardiovascular biomarkers in clinical studies of type 2 diabetes 75
Phenotyping normal kidney function in elderly patients with type 2 diabetes: a cross-sectional multicentre study 75
Totale 9.294
Categoria #
all - tutte 81.542
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 81.542


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020342 0 0 0 0 0 0 0 0 0 0 321 21
2020/20211.525 237 14 261 29 127 335 42 35 123 222 30 70
2021/20221.200 29 33 2 247 93 19 50 79 107 36 157 348
2022/20233.707 325 403 196 435 324 758 233 288 493 54 116 82
2023/20241.883 111 61 135 69 74 497 474 78 26 79 63 216
2024/20253.175 336 694 507 99 94 138 164 278 572 187 106 0
Totale 19.075